WASHINGTON — Confronted with Donald Trump’s unorthodox position on drug prices, the president-elect’s nominee to be secretary of health and human services on Wednesday appeared wary of proposals to allow Medicare to pursue negotiations on prescription drugs.
Congressman Tom Price, the Republican nominated by Trump to lead HHS, was asked by Democratic lawmakers whether he would agree to support empowering Medicare to negotiate prices with drug companies. After initially sidestepping those questions, he seemed to suggest that the policy would at least be considered, given Trump’s outspoken support for it, but he expressed no enthusiasm for the proposal.
